ABSTRACT
BACKGROUND: The present systematic review aims to investigate the guidelines for prescribing Preventive Antibiotic Therapy (PAT) in the placement of dental implants (DIs) without anatomical constraints in healthy patients by clinicians in Europe and to compare them with current recommendations. MATERIAL AND METHODS: A search was performed in 4 databases: Medline (via PubMed), Web of Science, Scopus, and LILACS. The criteria employed were those described in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) declaration (PROSPERO Registration number: CRD42022382278). RESULTS: The electronic search identified 10 studies published between 2010 and 2023 that met the established criteria. Overall, 60.8% ± 24.1% of European professionals routinely prescribe PAT, with the most frequent regimen being perioperative (mean= 46.7% ± 24.3%), followed by postoperative PAT only (mean= 20.3% ± 9.7%). CONCLUSIONS: The most commonly prescribed antibiotic both pre- and postoperatively is amoxicillin and, in allergic patients, clindamycin. In Europe, more doses of PAT are being prescribed than suggested by current recommendations. For this reason, more PAT education is needed in educational curricula to promote a more rational use of antibiotics to reduce the occurrence of antimicrobial resistance.
ABSTRACT
BACKGROUND: The number of patients treated with coagulation disorders, and more specifically with anticoagulant therapy, has increased worldwide in recent years due to increased life expectancy in developed countries. The protocols for managing this type of patient in oral surgery has varied over recent years, especially after the appearance of new direct-acting oral anticoagulants (DOACs). The assessment of risk of bleeding in this type of patient when undergoing a surgical procedure continues to be a controversial issue for patients, dentists and general practitioners. The objective of this document is to offer recommendations, based on evidence, for decision making for patients with coagulopathies who require dental surgical intervention. MATERIAL AND METHODS: Based on the indications of the "Preparation of Clinical Practice guidelines in the National Health System. Methodological manual", we gathered a group of experts who agreed on 15 PICO questions based on managing patients with coagulation disorders in dental surgical procedures, such as fitting of implants or dental extractions. RESULTS: The 15 PICO questions were answered based on the available evidence, being limited in most cases due to the lack of a control group. Two of the PICO questions were answered by the experts with a grade C recommendation, while the rest were answered with grade D. CONCLUSIONS: The results of this review highlight the need to undertake well designed clinical trials with control groups and with a representative sample size.
Subject(s)
Blood Coagulation Disorders , Oral Surgical Procedures , Surgery, Oral , Humans , Blood Coagulation Disorders/complications , Blood Coagulation Disorders/chemically induced , AnticoagulantsABSTRACT
La pérdida ósea marginal periimplantaria (MBL) es un proceso de remodelación no infeccioso que ocurre durante el primer año después de la colocación de un implante dental y todavía en la actualidad, sigue siendo un proceso complejo que sigue suscitando dudas. La asociación entre MBL y enfermedades periimplantarias todavía no está clara del todo, sin embargo, algunos autores así lo han establecido. Por este motivo, el control temprano de la MBL puede ser un factor clave en la prevención de la periimplantitis. Se han descrito factores generales y sistémicos del paciente, factores quirúrgicos asociados a la propia colocación del implante o a los tejidos duros y blandos que lo rodean, pero también a factores prostodónticos y de oclusión. El control de la posición del implante y el volumen de los tejidos, de la estabilidad primaria, de la inflamación postoperatoria y tardía, así como el momento de la carga, el tipo de prótesis o la forma y la altura del pilar, son algunos de los factores identificados como clave actualmente. El objetivo de este trabajo es describir desde un punto de vista reflexivo, la implicación de todos estos factores en el control de la MBL. (AU)
Peri-implant marginal bone loss (MBL) is a non-infectious remodelling process that occurs during the first year after the placement of a dental implant and even today, it remains a complex process that continues to raise questions. The association between MBL and peri-implant diseases is still not entirely clear, however, some authors have established it. For this reason, early control of MBL may be a key factor in the prevention of peri-implantitis. General and systemic factors of the patient have been described, surgical factors associated with the actual placement of the implant or the surrounding hard and soft tissues, but also prosthodontic and occlusion factors. The control of the position of the implant and the volume of the tissues, of the primary stability, of the postoperative and late inflammation, as well as the moment of the load, the type of prosthesis or the shape and height of the abutment, are some of the factors currently identified as key. The objective of this work is to describe, from a reflexive point of view, the implication of all these factors in the control of MBL. (AU)
